# Andréas Mackensen

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/andreas-mackensen/

## Facts

| Field | Value |
| --- | --- |
| Citations | 24,785 |
| Field | CAR-T cell therapy research |
| h-index | 74 |
| i10-index | 220 |
| Last Known Institution | Friedrich-Alexander-Universität Erlangen-Nürnberg |
| OpenAlex ID | https://openalex.org/A5081818015 |
| ORCID iD | https://orcid.org/0000-0002-0685-4483 |
| Works | 522 |

## Researcher papers

- [Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial](https://scholariq.org/papers/pembrolizumab-plus-pomalidomide-and-dexamethasone-for-patients-with-relapsed-or/)

## Researcher topics

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Researcher university

- [Friedrich-Alexander-Universität Erlangen-Nürnberg](https://scholariq.org/institutions/friedrich-alexander-universitat-erlangen-nurnberg/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.